This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

NICE guidance - management of duodenal ulcer (DU) in primary care

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Management of Duodenal Ulcer in Primary Care

Step (A) Stop NSAIDs if used - note that if NSAID continuation is necessary, after ulcer healing offer long-term gastric protection or consider substitution to a newer Cox-2-selective NSAID

Step (B) Test of H.pylori (use a carbon-13 urea breath test, stool antigen test or, when performance has been validated, laboratory-based serology)

  1. if test positive, ulcer associated with NSAID use then full-dose PPI for two months then (C)
  2. if test positive, ulcer not associated with NSAID use then (C)
  3. if test negative then full-dose PPI for one or two months
    1. if response after treatment then offer low-dose treatment, possibly on an as-required basis, with a limited number of repeat prescriptions then (D)
    2. if no response then exclude other causes of duoedenal ulcer 
      • consider: non-adherence with treatment, possible malignancy, failure to detect H. pylori infection due to recent PPI or antibiotic ingestion, inadequate testing or simple misclassification; surreptitious or inadvertent NSAID or aspirin use; ulceration due to ingestion of other drugs; Zollinger Ellison syndrome, Crohn's disease
      • review care annually, to discuss symptoms, promote stepwise withdrawal of therapy when appropriate and provide lifestyle advice.

Step (C) Eradication Therapy - triple therapy as per linked item

  1. if response then return to self-care
  2. if no response or relapse then re-test for H.pylori (use carbon-13 urea breath test or stool antigen test or when performance has been validated, laboratory-based serology)
    1. if positive then eradication therapy - as per linked item
    2. if negative then offer low-dose treatment, possibly on an as-required basis, then (D)
  3. if no response or relapse after second course of eradication therapy then offer low-dose treatment, possibly on an as-required basis, with a limited number of repeat prescriptions then (D)

Step (D) Assessment of response to low-dose treatment

  • if no response to low-dose treatment then exclude other causes of duoedenal ulcer
    • consider: non-adherence with treatment, possible malignancy, failure to detect H. pylori infection due to recent PPI or antibiotic ingestion, inadequate testing or simple misclassification; surreptitious or inadvertent NSAID or aspirin use; ulceration due to ingestion of other drugs; Zollinger Ellison syndrome, Crohn's disease
  • if response then review care annually, to discuss symptoms, promote stepwise withdrawal of therapy when appropriate and provide lifestyle advice.

For full details then refer to the full guideline (1).

Reference:

  1. NICE (September 2014).Dyspepsia and gastro-oesophageal reflux disease - Investigation and management of dyspepsia, symptoms suggestive of gastro-oesophageal reflux disease, or both

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.